Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ABSORB EXTEND Clinical Investigation: A Continuation in the Clinical Evaluation of the ABSORB Bioresorbable Vascular Scaffold (BVS) System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions

NCT01023789 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT01023789
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01023789 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ABSORB EXTEND Clinical Investigation: A Continuation in the Clinical Evaluation of the ABSORB Bioresorbable Vascular Scaffold (BVS) System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2010
Completion date
October 31, 2016
Enrollment
812 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, coronary artery disease, coronary artery stenosis, coronary disease, coronary restenosis, myocardial ischemia